Wird geladen...
Tumor necrosis factor inhibitors in psoriatic arthritis
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially. The clinical efficacy and the inhibition of radiographic progre...
Gespeichert in:
| Veröffentlicht in: | Expert Rev Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348387/ https://ncbi.nlm.nih.gov/pubmed/28490202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1329009 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|